Newsletter
Language
Language:
 
News
Archival Issues
Volume 19, 2017
Volume 18, 2016
Volume 17, 2015
Volume 16, 2014
Volume 15, 2013
Volume 14, 2012
Volume 13, 2011
Volume 12, 2010
Volume 11, 2009
Volume 10, 2008
Volume 9, 2007
Volume 8, 2006
Volume 7, 2005
Volume 6, 2004
Volume 5, 2003
Volume 4, 2002
Volume 3, 2001
Volume 2, 2000
Volume 1, 1999
Search
 » 
Journal Abstract
 
Clinical experience with the use of low molecular weight heparin in orthopaedic treatment of paediatric patients
Michał Latalski , Marek Fatyga , Marcin Misztal , Andrzej Gregosiewicz , Anna Danilewicz Bromberek
Ortop Traumatol Rehabil 2012; 14(4):329-333
ICID: 1005092
Article type: Original article
IC™ Value: 3.00
Abstract provided by Publisher
 
Summary
Introduction
The objective of the paper is to describe our clinical experience with the use of low molecular weight heparin in children treated due to various orthopaedic conditions.
Material and methods
We have studied the treatment outcomes of 35 patients aged 11 to 18 years who were hospitalized in the Department of Paediatric Orthopaedics and Department of Traumatology and Emergency Medicine of the Medical University of Lublin and were treated with a low molecular weight heparin (LMWH). Short-term prophylaxis was applied in 33 patients during immobilization after such orthopaedic procedures as surgical correction of spine deformity and corrective osteotomy of the femoral and tibial bone. Two children received LMWH therapy after reduction and fixation of femoral bone fractures and long-term immobilization following ankle joint distortion with early-stage venous thromboembolism (VTE).
Results
None of the patients who received prophylactic treatment showed the clinical manifestations of thrombosis. The VTE symptoms subsided in children treated with the LMWH. Nadroparin was administered for both short-term prophylaxis and treatment, and was administered in doses proportionate to body weight and without prior determination of anti-factor Xa activity (anti-Xa assay). No side effects were observed.
Conclusions
The use of the LMWH turned out to be effective and safe in thromboprophylaxis in paediatric patients.

ICID 1005092

DOI 10.5604/15093492.1005092
PMID 23043055 - click here to show this article in PubMed
 
FULL TEXT 221 KB


Related articles
  • in IndexCopernicus™
         low molecular weight heparin [4 related records]
         nadroparin [9 related records]
         orthopaedics [10 related records]
         children [1109 related records]
         venous thromboembolism [5 related records]
         thromboprophylaxis [1 related records]
         heparyna drobnocz─ůsteczkowa [0 related records]
         ortopedia dzieci [0 related records]

  • Related articlesin PubMed database
  • in PubMed database [ related records]


  •  

    Copyright © Ortopedia Traumatologia Rehabilitacja  2017
    Page created by Index Copernicus Ltd. All Rights reserved.